Qualifications
- Medical School: Oxford Medical School
- Qualification: BMBCh
- Date of award: 1995
- Professional College: Royal College of Obstetricians and Gynaecologists
- Qualification: MRCOG - Member Royal College of Obstetricians and Gynaecologists
- Date of award: 1999
- Other degree or qualification: University of Oxford
- Qualification: BA - Bachelor of Arts
- Date of award: 1992
- Other degree or qualification: University of Oxford
- Qualification: DPhil - Doctor of Philosophy
- Date of award: 2007
- Other degree or qualification: University of Oxford
- Qualification: MA - Master of Arts
- Date of award: 2000
Awards and Prizes
MRCOG Prize Medal 1999
Walport Clinical Lectureship (NIHR/CCRCD) 2007-2010
Wellbeing of Women Clinical Research Training Fellowship 2005-2007
Phizackerley Senior Scholarship, Balliol College, Oxford 2005
Stallworthy Prize for Obstetrics and Gynaecology, University of Oxford 1994
Gotch Memorial Prize, University of Oxford 1994
Martin Wronker Prize in Physiological Sciences, University of Oxford 1992
Hospital and Trust activities
Lead for Colposcopy Services
Professional affiliations and memberships
- British Society of Colposcopists and Cervical Pathologists
- British Gynaecological Cancer Society
- British Society for Gene Therapy
- Member of Royal College of Obstetricians and Gynaecologists
- Co-ordinating Editor for the Gynaecological Cancer Group of the Cochrane Collaboration
Research interests
Co-ordinating Editor for the Gynaecological Cancer Group of the Cochrane Collaboration
Summary of recent publications
Text Books
- Author(s): Morrison J., Kehoe S, Title: Cancer and Reproductive Health, Chapter: Epidemiolo, Year: 2008, Publisher: RCOG Press
- Author(s): Morrison, J, Title: The Oxford Handbook of Obstetrics and Gynaecology, Chapter: Malignant , Year: 2008, Publisher: OUP
- Author(s): Morrison, J., and Kehoe, S. , Title: In Women over 70: When normative treatment plans do not apply, Chapter: Gynaecolog, Year: 2007, Publisher: Informa Healthcare, London
- Author(s): Morrison J., and Kerr D. , Title: Cancer Therapy: Molecular Targets in Tumor-Host Interactions. , Chapter: Virus-dire, Year: 2005, Publisher: Horizon Scientific Press
- Author(s): Morrison, J., and MacKenzie, I.Z. , Title: The Abnormal Menstrual Cycle, Chapter: Uterine fi, Year: 2005, Publisher: Taylor and Francis
Journals
- Author(s): Morrison, J., Swanton, A., Collins, S., and Kehoe, S. , Title: Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer. , Journal: Cochrane Database Syst Rev, Volume: 4, Year: 2007, PageNo: CD005343. DOI: 10.1002/14651858.CD005343.pub2
- Author(s): Morrison, J., Briggs, S.S., Green, N., Thoma, C., Fisher, K.D., Kehoe, S., Seymour, L.W. , Title: Cetuximab retargeting of adenovirus via the epidermal growth factor receptor for treatment of intraperitoneal ovarian cancer., Journal: Hum Gene Ther , Volume: 20, Year: 2009, PageNo: 241–253
- Author(s): Morrison, J., Briggs, S. S., Green, N., Fisher, K., Subr, V., Ulbrich, K., Kehoe, S., and Seymour, L. W., Title: Virotherapy of Ovarian Cancer With Polymer-cloaked Adenovirus Retargeted to the Epidermal Growth Factor Receptor. , Journal: Mol Ther. , Volume: 16, Year: 2008, PageNo: 244-251
- Author(s): Green, N.K., Morrison, J., Hale, S., Briggs, S.S., Stevenson, M., Subr, V., Ulbrich, K., Chandler, L., Mautner, V., Seymour, L.W., and Fisher, K.D. , Title: Retargeting polymer-coated adenovirus to the FGF receptor allows productive infection and mediates efficacy in a peritoneal model of human ovarian cancer., Journal: J Gene Med, Volume: 10, Year: 2008, PageNo: 280-289
- Author(s): May, K., Bryant, A., Dickinson, H.O., Kehoe, S., and Morrison, J. , Title: Lymphadenectomy for the management of endometrial cancer., Journal: Cochrane Database of Systematic Reviews , Volume: 1, Year: 2009, PageNo: Art. No.: CD007585. DOI: 10.1002/14651858.CD007585
- Author(s): Martinek I, Haldar K, Gaitskell K, Bryant A, Nicum S, Kehoe S, Morrison J. , Title: DNA-repair pathway inhibitors for the treatment of ovarian cancer. , Journal: Cochrane Database of Systematic Reviews , Volume: 6, Year: 2010, PageNo: Art. No.: CD007929. DOI: 10.1002/14651858.CD007929
- Author(s): Kehoe, S., Morrison, J., Title: Ovarian cancer (advanced)., Journal: BMJ Clin Evid, Year: 2009, PageNo: http://clinicalevidence.bmj.com/ceweb/conditions/w
- Author(s): Kelly, B., Morrison, J., and Hurley, P., Title: Recent developments in HIV and women's health, Journal: Obstet Gynaecol (Lond) , Volume: 10, Year: 2008, PageNo: 42-48
- Author(s): Morrison, J., and MacKenzie, I.Z. , Title: Avoiding and managing complications during gynaecological surgery., Journal: Obst Gyn Repro Med, Volume: 17, Year: 2007, PageNo: 105-111
- Author(s): Morrison, J., and Kehoe, S. , Title: Key clinical trials in gynaecological oncology. , Journal: Eur J Surg Oncol., Volume: 32, Year: 2006, PageNo: 887-891
- Author(s): Morrison, J., Gillespie S., and MacKenzie, I.Z. , Title: 'Two week wait' standards for suspected gynaecological malignancy. On target, but missing the point? , Journal: J Br Menopause Soc , Volume: 9, Year: 2003, PageNo: 170-172
- Author(s): Morrison J., Elvin J., Latron F., Moots R., Gotch F.M., Strominger J.L. and McMichael A. , Title: Identification of the nonamer peptide from influenza A matrix protein and the role of pockets of HLA-A2 in its recognition by cytotoxic T lymphocytes. , Journal: European Journal of Immunology, Volume: 22, Year: 1992, PageNo: 903-907
- Author(s): Latron F., Pazmany L., Morrison J., Moots R., Saper M.A., McMichael A. and Strominger J.L. , Title: A critical role for conserved residues in the cleft of HLA-A2 in presentation of a nonapeptide to T cells. , Journal: Science, Volume: 257, Year: 1992, PageNo: 964-9
- Author(s): Morrison J, Haldar K, Kehoe S, Lawrie TA. , Title: Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer. , Journal: Cochrane Database of Systematic Reviews, Volume: 8, Year: 2012, PageNo: Art. No.: CD005343. DOI: 10.1002/14651858
- Author(s): Haldar K, Gaitskell K, Bryant A, Nicum S, Kehoe S, Morrison J., Title: Epidermal growth factor receptor blockers for the treatment of ovarian cancer., Journal: Cochrane Database of Systematic Reviews, Volume: 10, Year: 2011, PageNo: Art. No.: CD007927. DOI: 10.1002/14651858.CD007927
- Author(s): Gaitskell K, Martinek I, Bryant A, Kehoe S, Nicum S, Morrison J. , Title: Angiogenesis inhibitors for the treatment of ovarian cancer., Journal: Cochrane Database of Systematic Reviews , Volume: 9, Year: 2011, PageNo: Art. No.: CD007930. DOI: 10.1002/14651858.CD007930
Audit / Outcomes
Outcomes routinely recorded:
Patient assessed outcome measures
Mortality
- SF36 or other Short Form measure : No
- HRQOL : No
- Locally produced questionnaire : Yes
- (Please specify) : patient satisfaction scores
- Peri-operative infection rate : Yes
- Late infection rate : No
- Peri-operative : Yes
- 30 day : Yes
- Longer term : Yes
- Time period : 5 year data available for service via ASW Cancer Network
- Complication rates : Yes
- Details : see below for details
- Data recorded for all patients or only summary statistics?
: Patients
- Information held electronically or on paper? : Electronic
- Data benchmarked against other surgeons or centres using the same methodology? : No
- Data regularly reviewed or analysed by department?
: Yes
- Audit results
: Since its introduction in March 2011, we routinely collect data as part of the Gynaecological Cancer Enhanced Recovery Programme about patient satisfaction score, length of stay following laparotomy and laparoscopic surgery, route of surgery for endometrial cancer (%laparoscopic vs open), pain score on movement after laparotomy, time to mobilisation after lapaprotomy and complications.
Cancer wait time data routinely collected as are colposcopy quality assurance data for the National Cervical Screening Programme.
